For Moberg Pharma Some believe the newspaper on strong growth thanks to the US ahead.
Cellavision play both Europe and Asia role in growth, and the dollar gives a ride.
Hansa Medical drug candidate that will prevent rejection of transplanted kidneys is interesting and has recently presented promising preliminary Phase II data and has highly qualified owner Bengt Ågerup.
IVF company Vitrolife has high p / e ratio, but also high growth and profitability – as well as credibility, thanks to previous positive margin surprises, reminds Börsveckan as well as the good demographic conditions with increasing average age for first-time parents.
Global Health Partner , however, may Council await, partly because of political risk from left government of Limitations gain in welfare – even though this risk should not be exaggerated.
Outside the sector may kontanthanteraren Loomis and the security company Securitas neutral recommendations, while buying opportunity now considered to exist in the ventilation company Systemair.
No comments:
Post a Comment